Bioscience

Biozona Weekly: ASU tech transfer; UA virus study; Q&A with C-Path CEO

December 12, 2014

By Flinn Foundation

ASU tech transfer arm earns high rankings for inventions, startups, innovation
12/11/14 | Phoenix Business Journal | Angela Gonzales

Arizona State University’s technology transfer arm achieved high rankings for the third year in a row in innovation metrics such as invention disclosures, startups, and licensing agreements, while the state’s three research universities totaled nearly $1.1 billion in research expenditures.

Students earn college credit in STEM at Grand Canyon University
12/9/14 | Arizona Republic | Miranda Rivers (Cronkite News)

Grand Canyon University President Brian Mueller touted his school’s new STEM program while in Washington, D.C., that he says targets students from inner cities to help them get involved and succeed in science, technology, engineering and mathematics fields.

UA research studies dormant viruses, possible effects
12/5/14 | KGUN | Rikki Mitchell

University of Arizona researchers received a Flinn Foundation grant to study Cytomegalovirus in the lab to learn how the virus could affect patients when they enter a diseased state, and to hopefully come up with better treatment options and possibly a vaccine.

ASU researchers work to develop handheld DNA reader

12/4/14 | KJZZ | Mark Brodie

Researchers at ASU and IBM are working on a handheld device that could read a patient’s DNA from a very small amount of blood, spit or other fluid.

Q&A: Critical Path has big plans for Flinn grant

11/28/14 | Phoenix Business Journal | Angela Gonzales

Critical Path Institute CEO Martha Brumfield speaks with the Phoenix Business Journal about new grants received by the Tucson-based nonprofit as well as its ties to the Arizona Alzheimer’s Consortium.